These compounds may interact with:
Perilipin-5
Potentially involved in: obesity; fatty liver disease; ductal carcinoma in situ; fibroadenoma; gastric carcinoma; interstitial cystitis; intraductal papillary-mucinous neoplasm (ipmn); invasive ductal carcinoma; ovarian cancer; pancreatic cancer; pituitary cancer; tuberculosis
Disease data sourced from Pharos.